一种受体对抗剂平衡番茄中的多种系统细胞因子
Lei Wang1, Louis-Philippe Maier2, Nga Pham3
1Yazhouwan National Laboratory, Sanya 572024, Hainan, China; ZMBP, University of Tübingen, Tübingen 72076, Germany; Institute of Plant Sciences, University of Bern, Bern 3013, Switzerland.
Cell
|August 22, 2025
概括
植物使用抗SYS抑制免疫刺激性植物细胞因子,确保免疫平衡. 这种作为天然抗剂,对番茄植物生长和生殖健康至关重要.
科学领域:
- 植物生物学
- 分子植物病原体相互作用
- 植物免疫力
背景情况:
- 植物的免疫激活需要严格的调节以保持最佳健康.
- 植物控制免疫刺激性植物细胞因子的机制尚未完全理解.
- 植物细胞因子在植物的防御和发育中起着至关重要的作用.
研究的目的:
- 确定番茄细胞因子系统的天然抑制剂.
- 阐明抗SYS在调节植物免疫反应中的作用.
- 了解抗SYS作为植物细胞因子活性调节者的机制.
主要方法:
- 鉴定抗SYS是一种类系统.
- 对抗SYS作为系统因子受体的特定抗剂的表征.
- 分析缺乏抗SYS的番茄突变,以评估表型后果.
主要成果:
- 抗SYS是一种新的番茄细胞因子系统的抑制剂.
- 抗SYS作为一个强大的和特定的系统因子受体对抗剂.
- 缺乏抗SYS的番茄突变体表现出异常生长和降低生殖能力.
结论:
- 对于调节番茄植物中的植物细胞因子活动,AntiSYS是必不可少的.
- 抗SYS可以平衡激活系统因子,维持免疫平衡.
- 这一发现提供了跨王国免疫调节的保存机制的见解.
相关概念视频
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Cell Signaling in Plants
5.7K
Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
5.7K
Drug-Receptor Interaction: Antagonist
3.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.4K
Combined Effects of Drugs: Antagonism
9.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.2K
The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K


